Amarin Corp Plc (AMRN) Stock Price

AMRNStock
$14.1513.39%52W
Market Cap$298.89M
P/E
PEG Ratio0.81
Div yield
Beta0.75

AMRN Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-23.43%
Price vs S&P 500 (4W)-3.84%
PEG Ratio0.81
VGM Score41.55

AMRN Earnings Surprise History

Q2 250.87est. -0.61
Q3 250.19est. 0.00
Q4 250.01est. 0.07
Q1 260.00est. 0.17
Q2 26-0.02est. -0.01

AMRN Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
2.14
2.14
2.14
2.00

Industry Peers — Pharmaceuticals(571)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
AMRNAmarin Corp Plc
BFC$14.15
LLYEli Lilly & Co.DBB$1233.66
JNJJohnson & JohnsonDCB$273.14
ABBVABBVIE INC.DCB$265.79
MRKMerck & Co., Inc.DCA$156.45
NVSNovartis AGCCC$159.98
AZNAstraZeneca PLCCBC$169.66
NVONovo-Nordisk A/SBCC$48.66
ABTAbbott LaboratoriesCCB$116.13
PFEPfizer Inc.CDC$28.57
VRTXVertex Pharmaceuticals IncDCB$552.85

About Amarin Corp Plc

Amarin Corporation PLC is a pharmaceutical company specializing in cardiovascular health therapeutics. The company commercializes Vascepa, a treatment designed to reduce cardiovascular risk and prevent CV-related mortality. Amarin derives the majority of its revenue from the United States market.